| scholarly article | Q13442814 |
| P50 | author | Hans-Joachim Anders | Q46256091 |
| Matthias Kretzler | Q30004156 | ||
| P2093 | author name string | Daniel Zecher | |
| Prashant S Patole | |||
| Rahul D Pawar | |||
| Detlef Schlöndorff | |||
| Stephan Segerer | |||
| P433 | issue | 1 | |
| P921 | main subject | toll-like receptor | Q408004 |
| glomerulonephritis | Q605006 | ||
| P304 | page(s) | 141-149 | |
| P577 | publication date | 2005-11-09 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Toll-like receptor-7 modulates immune complex glomerulonephritis | |
| P478 | volume | 17 |
| Q36490737 | Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed mice |
| Q34364711 | B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers. |
| Q43744733 | Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier |
| Q38206875 | Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis |
| Q26741199 | Chemokines and Chemokine Receptors in the Development of Lupus Nephritis |
| Q42141284 | Cytokine-induced monocyte characteristics in SLE |
| Q36659210 | Cytokines in systemic lupus erythematosus |
| Q37581431 | Dendritic cells and macrophages in kidney disease |
| Q37693713 | Endosomal Toll-like receptors in autoimmunity: mechanisms for clinical diversity |
| Q51516999 | Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice. |
| Q53633821 | Expression of Toll-like receptors in the kidney: their potential role beyond infection. |
| Q39603954 | Four danger response programs determine glomerular and tubulointerstitial kidney pathology: clotting, inflammation, epithelial and mesenchymal healing |
| Q40305947 | Hyaluronan is not a ligand but a regulator of toll-like receptor signaling in mesangial cells: role of extracellular matrix in innate immunity. |
| Q37739204 | Innate immune receptors and autophagy: implications for autoimmune kidney injury. |
| Q35125991 | Interferon regulatory factor 1 marks activated genes and can induce target gene expression in systemic lupus erythematosus |
| Q37710960 | Interferon-alpha and -beta in kidney inflammation |
| Q35557898 | Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity |
| Q36905450 | Leptospirosis renal disease: understanding the initiation by Toll-like receptors |
| Q36972471 | Leukocytes in glomerular injury |
| Q50589122 | Long-term follow-up after non-myeloablative transplant of bone and marrow in BXSB mice. |
| Q91595484 | Low-dose 17α-ethinyl estradiol (EE) exposure exacerbates lupus renal disease and modulates immune responses to TLR7/9 agonists in genetically autoimmune-prone mice |
| Q35758450 | Mdm2 promotes systemic lupus erythematosus and lupus nephritis |
| Q37956536 | Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity |
| Q81527709 | Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus |
| Q80866796 | Monocytosis in BXSB mice is due to epistasis between Yaa and the telomeric region of chromosome 1 but does not drive the disease process |
| Q39016144 | New insights into the immunopathogenesis of systemic lupus erythematosus. |
| Q36732312 | No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation |
| Q34017633 | Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus |
| Q33396543 | Pathway of Toll-like receptor 7/B cell activating factor/B cell activating factor receptor plays a role in immune thrombocytopenia in vivo |
| Q38217071 | Pattern recognition receptors and the inflammasome in kidney disease. |
| Q43106918 | Plasma exchange in severe leptospirosis with multi-organ failure: a case report |
| Q36604951 | Renal Toll-like receptors: recent advances and implications for disease |
| Q37911240 | Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. |
| Q37587328 | Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy |
| Q38698593 | Small RNAs induce the activation of the pro-inflammatory TLR7 signaling pathway in aged rat kidney |
| Q37234883 | Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice |
| Q36666867 | TLR4 links podocytes with the innate immune system to mediate glomerular injury |
| Q39136868 | TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells |
| Q37019634 | TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus |
| Q37733130 | TLR7-expressing cells comprise an interfollicular epidermal stem cell population in murine epidermis |
| Q28292240 | TLR8 deficiency leads to autoimmunity in mice |
| Q36423215 | Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus. |
| Q38682337 | The mucosa-kidney axis in IgA nephropathy |
| Q37696961 | The role of Toll-like receptors in renal diseases |
| Q36973585 | Therapeutic impact of toll-like receptors on inflammatory bowel diseases: a multiple-edged sword |
| Q38003021 | Tissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis. |
| Q38068399 | Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments. |
| Q99549625 | Toll-Like Receptor as a Potential Biomarker in Renal Diseases |
| Q35004877 | Toll-like receptor 2 or toll-like receptor 4 deficiency does not modify lupus in MRLlpr mice |
| Q35720839 | Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy |
| Q52323268 | Toll-like receptors in lupus nephritis. |
| Q38168570 | Toll-like receptors signaling in glomerular diseases |
| Q33877996 | Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. |
| Q35498054 | Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus |
| Q82607442 | Viral 5'-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses |
| Q34356566 | Yaa autoimmune phenotypes are conferred by overexpression of TLR7. |
Search more.